AU2003222173A1 - Nucleic acid compositions and methods for use - Google Patents

Nucleic acid compositions and methods for use

Info

Publication number: AU2003222173A1
Authority: AU; Australia
Prior art keywords: methods; nucleic acid; acid compositions; compositions; nucleic
Prior art date: 2003-04-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003222173A

Inventor

Patrick J. Branigan

Theresa J. Goletz

David M. Knight

Stephen G. Mccarthy

Bernard J. Scallon

Linda A. Snyder

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Janssen Biotech Inc

Original Assignee

Centocor Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-01

Filing date

2003-04-01

Publication date

2004-11-23

2003-04-01 Application filed by Centocor Inc filed Critical Centocor Inc

2004-11-23 Publication of AU2003222173A1 publication Critical patent/AU2003222173A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Molecular Biology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU2003222173A 2003-04-01 2003-04-01 Nucleic acid compositions and methods for use Abandoned AU2003222173A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US2003/010096 WO2004096238A1 (en)	2003-04-01	2003-04-01	Nucleic acid compositions and methods for use

Publications (1)

Publication Number	Publication Date
AU2003222173A1 true AU2003222173A1 (en)	2004-11-23

Family

ID=33415186

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003222173A Abandoned AU2003222173A1 (en)	2003-04-01	2003-04-01	Nucleic acid compositions and methods for use

Country Status (2)

Country	Link
AU (1)	AU2003222173A1 (en)
WO (1)	WO2004096238A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2023226512A1 (en)	2022-02-23	2024-08-29	Bright Peak Therapeutics Ag	Immune antigen specific il-18 immunocytokines and uses thereof
CA3244053A1 (en) *	2022-02-23	2023-08-31	Bright Peak Therapeutics Ag	Modified il-18 polypeptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6013268A (en) *	1994-04-22	2000-01-11	Corixa Corporation	Methods for enhancement of protective immune responses
DE19648625A1 (en) *	1996-11-13	1998-05-14	Soft Gene Gmbh	Microprojectile for the introduction of substances into cells by ballistic transfer
US6387888B1 (en) *	1998-09-30	2002-05-14	American Foundation For Biological Research, Inc.	Immunotherapy of cancer through expression of truncated tumor or tumor-associated antigen
US6495130B1 (en) *	1998-12-30	2002-12-17	Calydon, Inc.	Target cell-specific adenoviral vectors containing E3 and methods of use thereof

2003
- 2003-04-01 AU AU2003222173A patent/AU2003222173A1/en not_active Abandoned
- 2003-04-01 WO PCT/US2003/010096 patent/WO2004096238A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2004096238A1 (en)	2004-11-11

Similar Documents

Publication	Publication Date	Title
AU2003239129A1 (en)	2003-10-27	Methods and compositions for dna manipulation
AU2003257013A1 (en)	2005-03-07	Methods and compositions for amplification of dna
AU2003300099A1 (en)	2004-07-29	COMPOSITIONS AND METHODS FOR INHIBITING TGF-Beta
AU2003270310A1 (en)	2004-03-29	Compositions and methods for synthesizing nucleic acids
AU2003256805A1 (en)	2004-02-09	Compounds compositions and methods
AU2003257109A1 (en)	2004-02-23	Compositions and methods for molecular biology
AU2003214887A1 (en)	2003-09-02	Compositions and methods for polynucleotide sequence determination
AU2003303588A1 (en)	2004-07-29	Methods and compositions for sequencing nucleic acid molecules
GB0608813D0 (en)	2006-06-14	Improved methods and compositions for RNA interference
WO2005110009A8 (en)	2008-05-22	COMPOSITIONS AND METHODS RELATING TO TSP-30a, b, c AND d
AU2003230619A1 (en)	2003-09-22	Compositions and methods for detecting nucleic acid methylation
AU2003230070A1 (en)	2003-11-11	Isolating nucleic acid
AU2003287249A1 (en)	2004-06-03	Organic acid containing compositions and methods for use thereof
AU2003269991A1 (en)	2005-03-10	Polymerase compositions
AU2003209211A1 (en)	2003-07-30	Methods and compositions for assaying homocysteine
AU2003222173A1 (en)	2004-11-23	Nucleic acid compositions and methods for use
AU2003100144A4 (en)	2003-07-10	Lousicide composition
AU2003219396A1 (en)	2003-11-10	Isolating nucleic acid
AU2003295732A1 (en)	2005-07-14	Nucleic acid amplification methods
WO2004048516A3 (en)	2006-02-23	Elf3 gene compositions and methods
AU2003224928A1 (en)	2003-12-12	Compositions and methods for cloning nucleic acids
HK1095096A (en)	2007-04-27	Methods and compositions
AU2003906800A0 (en)	2004-01-08	Composition and Methods
AU2003904603A0 (en)	2003-09-11	Nucleic acid molecule and uses therefor
HK1082741A (en)	2006-06-16	Methods and compositions for rna interference

Legal Events

Date	Code	Title	Description
2005-12-15	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase